Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy
Announces $1.0 Billion Share Repurchase Program for Q4 2022 Separately Enters Into Agreement to Acquire The Binding Site Group WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment. Throughout the fourth quarter of 2022, Thermo Fisher expects to execute a... Read more